Uther's sentiment score landed at 0.467 — below the neutral midpoint — across 79 mentions and 242 posts in the current window, a result shaped by opposing theme clusters rather than a single dominant signal. Mined concern themes for the window included alleged scam, endotoxin concerns, shady reports, stock issues, and overpriced; mined praise themes included US domestic shipping, trust signal, good pricing, no issues reported, and third-party tested. No representative quotes were captured, and no anchor threads are available, so both lists reflect extracted discussion signal, not verified assertions attributed to named authors.

The window context shows 188 active authors across 503 total forum-wide posts and 108 threads — a 28-percent author-count decline versus the prior period at the forum level, not specific to Uther's subforum. That baseline shift will either be confirmed or contradicted by next-window volume.

A thread opened 19 hours ago has accumulated 73 community posts.

Community discussion of retatrutide has surfaced an unexpected pattern: users reporting heightened rather than diminished libido — a signal that runs counter to the suppressed-desire effects more commonly documented with GLP-1 receptor agonists in this class. The thread, opened 19 hours ago, has drawn 73 posts.